TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Boston Scientific Nordic AB
Closing information (x1000 DKK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
919,094
|
901,269
|
798,835 |
| Financial expenses |
99
|
549
|
302 |
| Earnings before taxes |
23,977
|
28,830
|
21,317 |
| EBITDA |
28,022
|
33,128
|
26,111 |
| Total assets |
327,013
|
297,951
|
281,265 |
| Current assets |
312,333
|
283,732
|
268,721 |
| Current liabilities |
166,967
|
153,347
|
156,306 |
| Equity capital |
160,047
|
144,604
|
124,960 |
| - share capital |
65
|
67
|
67 |
| Employees (average) |
136
|
126
|
120 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
48.9%
|
48.5%
|
44.4% |
| Turnover per employee |
6,758
|
7,153
|
6,657 |
| Profit as a percentage of turnover |
2.6%
|
3.2%
|
2.7% |
| Return on assets (ROA) |
7.4%
|
9.9%
|
7.7% |
| Current ratio |
187.1%
|
185.0%
|
171.9% |
| Return on equity (ROE) |
15.0%
|
19.9%
|
17.1% |
| Change turnover |
47,635
|
98,320
|
70,961 |
| Change turnover % |
5%
|
12%
|
10% |
| Chg. No. of employees |
10
|
6
|
7 |
| Chg. No. of employees % |
8%
|
5%
|
6% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.